US Stock MarketDetailed Quotes

CMMB Chemomab Therapeutics

Watchlist
  • 1.300
  • -0.210-13.91%
Close Mar 4 16:00 ET
24.51MMarket Cap-1.38P/E (TTM)

Chemomab Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-27.89%14.27M
-27.89%14.27M
--19.38M
-52.13%12.73M
-51.46%15.88M
-50.41%19.78M
--19.78M
-48.59%26.59M
-43.03%32.71M
-34.77%39.89M
-Cash and cash equivalents
-34.66%6.07M
-34.66%6.07M
--6.6M
-51.49%5.04M
-77.53%4.67M
-31.27%9.29M
--9.29M
5.05%10.38M
50.18%20.77M
-10.98%13.52M
-Short-term investments
-21.89%8.2M
-21.89%8.2M
--12.78M
-52.55%7.69M
-6.11%11.21M
-60.22%10.49M
--10.49M
-61.27%16.21M
-72.60%11.94M
-42.63%26.37M
Receivables
487.54%1.7M
487.54%1.7M
--439K
-37.24%654K
-11.06%885K
-37.04%289K
--289K
-66.45%1.04M
-48.55%995K
156.42%459K
-Other receivables
487.54%1.7M
487.54%1.7M
--439K
-37.24%654K
-11.06%885K
-37.04%289K
--289K
-66.45%1.04M
-48.55%995K
156.42%459K
Prepaid assets
----
----
----
----
----
-42.77%748K
--748K
----
----
-3.04%1.31M
Restricted cash
0.00%76K
0.00%76K
--75K
0.00%74K
-2.60%75K
-1.30%76K
--76K
--74K
--77K
--77K
Total current assets
-23.24%16.04M
-23.24%16.04M
--19.89M
-51.43%13.46M
-50.15%16.84M
-49.93%20.9M
--20.9M
-49.47%27.71M
-43.08%33.78M
-33.42%41.74M
Non current assets
Net PPE
-22.45%539K
-22.45%539K
--577K
23.90%617K
20.37%656K
17.00%695K
--695K
-23.38%498K
-18.29%545K
-15.38%594K
-Gross PPE
-41.48%539K
-41.48%539K
--577K
23.90%617K
20.37%656K
21.34%921K
--921K
-23.38%498K
-18.29%545K
-6.18%759K
-Accumulated depreciation
----
----
----
----
----
-36.97%-226K
---226K
----
----
-54.21%-165K
Non current prepaid assets
-31.13%385K
-31.13%385K
--428K
-26.93%472K
-25.22%516K
-23.74%559K
--559K
-21.32%646K
-20.14%690K
-19.27%733K
Total non current assets
-26.32%924K
-26.32%924K
--1.01M
-4.81%1.09M
-5.10%1.17M
-5.50%1.25M
--1.25M
-26.10%1.14M
-23.58%1.24M
-20.30%1.33M
Total assets
-23.42%16.96M
-23.42%16.96M
--20.9M
-49.59%14.54M
-48.56%18.01M
-48.56%22.15M
--22.15M
-48.83%28.85M
-42.56%35.01M
-33.08%43.06M
Liabilities
Current liabilities
Payables
29.07%666K
29.07%666K
--386K
-52.58%1.11M
-76.23%527K
-69.43%516K
--516K
63.78%2.35M
49.09%2.22M
26.35%1.69M
-accounts payable
29.07%666K
29.07%666K
--386K
-52.58%1.11M
-76.23%527K
-69.43%516K
--516K
63.78%2.35M
49.09%2.22M
26.35%1.69M
Current accrued expenses
-54.34%1.56M
-54.34%1.56M
--3.12M
1.72%2.55M
7.49%3.4M
1.33%3.42M
--3.42M
46.20%2.5M
153.53%3.16M
508.65%3.38M
Current debt and capital lease obligation
51.32%115K
51.32%115K
--112K
0.93%109K
-4.35%110K
-38.21%76K
--76K
-18.18%108K
-0.86%115K
16.04%123K
-Current capital lease obligation
51.32%115K
51.32%115K
--112K
0.93%109K
-4.35%110K
-38.21%76K
--76K
-18.18%108K
-0.86%115K
16.04%123K
Current liabilities
-33.48%3.22M
-33.48%3.22M
--4.35M
-36.88%4.31M
-37.14%4.4M
-28.32%4.84M
--4.84M
55.33%6.83M
98.95%7M
154.68%6.75M
Non current liabilities
Long term debt and capital lease obligation
-33.86%209K
-33.86%209K
--230K
660.61%251K
351.61%280K
247.25%316K
--316K
-77.70%33K
-69.46%62K
-61.60%91K
-Long term capital lease obligation
-33.86%209K
-33.86%209K
--230K
660.61%251K
351.61%280K
247.25%316K
--316K
-77.70%33K
-69.46%62K
-61.60%91K
Total non current liabilities
-33.86%209K
-33.86%209K
--230K
660.61%251K
351.61%280K
247.25%316K
--316K
-77.70%33K
-69.46%62K
-61.60%91K
Total liabilities
-33.51%3.43M
-33.51%3.43M
--4.58M
-33.52%4.56M
-33.73%4.68M
-24.65%5.15M
--5.15M
50.99%6.86M
89.76%7.06M
136.92%6.84M
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-15.73%-102.62M
-15.73%-102.62M
---99.66M
-19.41%-96.18M
-27.52%-92.55M
-38.95%-88.68M
---88.68M
-69.68%-80.54M
-75.82%-72.57M
-76.43%-63.82M
Paid-in capital
9.92%116.16M
9.92%116.16M
--115.98M
2.32%106.16M
4.06%105.88M
4.36%105.68M
--105.68M
4.48%103.75M
3.28%101.74M
3.71%101.26M
Less: Treasury stock
----
----
----
----
----
--0
--0
--1.22M
--1.22M
--1.22M
Total stockholders'equity
-20.36%13.54M
-20.36%13.54M
--16.32M
-54.60%9.99M
-52.31%13.33M
-53.08%17M
--17M
-57.58%21.99M
-51.16%27.95M
-41.07%36.22M
Total equity
-20.36%13.54M
-20.36%13.54M
--16.32M
-54.60%9.99M
-52.31%13.33M
-53.08%17M
--17M
-57.58%21.99M
-51.16%27.95M
-41.07%36.22M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
--
Unqualified Opinion
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -27.89%14.27M-27.89%14.27M--19.38M-52.13%12.73M-51.46%15.88M-50.41%19.78M--19.78M-48.59%26.59M-43.03%32.71M-34.77%39.89M
-Cash and cash equivalents -34.66%6.07M-34.66%6.07M--6.6M-51.49%5.04M-77.53%4.67M-31.27%9.29M--9.29M5.05%10.38M50.18%20.77M-10.98%13.52M
-Short-term investments -21.89%8.2M-21.89%8.2M--12.78M-52.55%7.69M-6.11%11.21M-60.22%10.49M--10.49M-61.27%16.21M-72.60%11.94M-42.63%26.37M
Receivables 487.54%1.7M487.54%1.7M--439K-37.24%654K-11.06%885K-37.04%289K--289K-66.45%1.04M-48.55%995K156.42%459K
-Other receivables 487.54%1.7M487.54%1.7M--439K-37.24%654K-11.06%885K-37.04%289K--289K-66.45%1.04M-48.55%995K156.42%459K
Prepaid assets ---------------------42.77%748K--748K---------3.04%1.31M
Restricted cash 0.00%76K0.00%76K--75K0.00%74K-2.60%75K-1.30%76K--76K--74K--77K--77K
Total current assets -23.24%16.04M-23.24%16.04M--19.89M-51.43%13.46M-50.15%16.84M-49.93%20.9M--20.9M-49.47%27.71M-43.08%33.78M-33.42%41.74M
Non current assets
Net PPE -22.45%539K-22.45%539K--577K23.90%617K20.37%656K17.00%695K--695K-23.38%498K-18.29%545K-15.38%594K
-Gross PPE -41.48%539K-41.48%539K--577K23.90%617K20.37%656K21.34%921K--921K-23.38%498K-18.29%545K-6.18%759K
-Accumulated depreciation ---------------------36.97%-226K---226K---------54.21%-165K
Non current prepaid assets -31.13%385K-31.13%385K--428K-26.93%472K-25.22%516K-23.74%559K--559K-21.32%646K-20.14%690K-19.27%733K
Total non current assets -26.32%924K-26.32%924K--1.01M-4.81%1.09M-5.10%1.17M-5.50%1.25M--1.25M-26.10%1.14M-23.58%1.24M-20.30%1.33M
Total assets -23.42%16.96M-23.42%16.96M--20.9M-49.59%14.54M-48.56%18.01M-48.56%22.15M--22.15M-48.83%28.85M-42.56%35.01M-33.08%43.06M
Liabilities
Current liabilities
Payables 29.07%666K29.07%666K--386K-52.58%1.11M-76.23%527K-69.43%516K--516K63.78%2.35M49.09%2.22M26.35%1.69M
-accounts payable 29.07%666K29.07%666K--386K-52.58%1.11M-76.23%527K-69.43%516K--516K63.78%2.35M49.09%2.22M26.35%1.69M
Current accrued expenses -54.34%1.56M-54.34%1.56M--3.12M1.72%2.55M7.49%3.4M1.33%3.42M--3.42M46.20%2.5M153.53%3.16M508.65%3.38M
Current debt and capital lease obligation 51.32%115K51.32%115K--112K0.93%109K-4.35%110K-38.21%76K--76K-18.18%108K-0.86%115K16.04%123K
-Current capital lease obligation 51.32%115K51.32%115K--112K0.93%109K-4.35%110K-38.21%76K--76K-18.18%108K-0.86%115K16.04%123K
Current liabilities -33.48%3.22M-33.48%3.22M--4.35M-36.88%4.31M-37.14%4.4M-28.32%4.84M--4.84M55.33%6.83M98.95%7M154.68%6.75M
Non current liabilities
Long term debt and capital lease obligation -33.86%209K-33.86%209K--230K660.61%251K351.61%280K247.25%316K--316K-77.70%33K-69.46%62K-61.60%91K
-Long term capital lease obligation -33.86%209K-33.86%209K--230K660.61%251K351.61%280K247.25%316K--316K-77.70%33K-69.46%62K-61.60%91K
Total non current liabilities -33.86%209K-33.86%209K--230K660.61%251K351.61%280K247.25%316K--316K-77.70%33K-69.46%62K-61.60%91K
Total liabilities -33.51%3.43M-33.51%3.43M--4.58M-33.52%4.56M-33.73%4.68M-24.65%5.15M--5.15M50.99%6.86M89.76%7.06M136.92%6.84M
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -15.73%-102.62M-15.73%-102.62M---99.66M-19.41%-96.18M-27.52%-92.55M-38.95%-88.68M---88.68M-69.68%-80.54M-75.82%-72.57M-76.43%-63.82M
Paid-in capital 9.92%116.16M9.92%116.16M--115.98M2.32%106.16M4.06%105.88M4.36%105.68M--105.68M4.48%103.75M3.28%101.74M3.71%101.26M
Less: Treasury stock ----------------------0--0--1.22M--1.22M--1.22M
Total stockholders'equity -20.36%13.54M-20.36%13.54M--16.32M-54.60%9.99M-52.31%13.33M-53.08%17M--17M-57.58%21.99M-51.16%27.95M-41.07%36.22M
Total equity -20.36%13.54M-20.36%13.54M--16.32M-54.60%9.99M-52.31%13.33M-53.08%17M--17M-57.58%21.99M-51.16%27.95M-41.07%36.22M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------------Unqualified Opinion
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.